Chongqing Zhifei Biological Products Co., Ltd.: COVID-19 trials
The registry lists 11 COVID-19 studies with Chongqing Zhifei Biological Products Co., Ltd. as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 3 5Phase 4 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Safety Study of COVID19 Vaccine on the MarketRecruitingNCT05890521Phase 4
- Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical TrialStatus unknownNCT06043388Phase 1
- To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2CompletedNCT05895110Not applicable
- A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)Status unknownNCT05616754Phase 3
- Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)CompletedNCT05574985Not applicable
- Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Status unknownNCT05128643Phase 3
- Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)CompletedNCT05109598Phase 2
- Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza VaccineCompletedNCT05107375Phase 3
- Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)Status unknownNCT05091411Phase 3
- Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing ImmunityCompletedNCT05089045Not applicable
- A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19Status unknownNCT04646590Phase 3